Use of IL-23 antagonists for treatment of infection

Details for Australian Patent Application No. 2008262544 (hide)

Owner SCHERING CORPORATION

Inventors Kastelein, Robert A.; Romani, Luigina; Chackerian, Alissa A.; Kopf, Manfred

Agent Griffith Hack

Pub. Number AU-A-2008262544

PCT Pub. Number WO2008/153610

Priority 60/889,475 12.02.07 US

Filing date 8 February 2008

Wipo publication date 18 December 2008

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

3 September 2009 PCT application entered the National Phase

  PCT publication WO2008/153610 Priority application(s): WO2008/153610

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008262545-Sustained delivery formulations of risperidone compounds

2008262540-Systems and methods for personalizing an interactive media guidance application